Free Trial
OTCMKTS:BIOVF

Swedish Orphan Biovitrum (BIOVF) Stock Price, News & Analysis

Swedish Orphan Biovitrum logo
$30.75 +1.78 (+6.14%)
As of 08/22/2025 10:26 AM Eastern

About Swedish Orphan Biovitrum Stock (OTCMKTS:BIOVF)

Key Stats

Today's Range
$30.00
$30.75
50-Day Range
$27.06
$31.99
52-Week Range
$25.80
$32.25
Volume
243 shs
Average Volume
39 shs
Market Capitalization
$10.95 billion
P/E Ratio
25.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive BIOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter.

BIOVF Stock News Headlines

Sobi has completed issues of class C shares
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
See More Headlines

BIOVF Stock Analysis - Frequently Asked Questions

Swedish Orphan Biovitrum's stock was trading at $27.66 at the start of the year. Since then, BIOVF stock has increased by 11.2% and is now trading at $30.75.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) announced its quarterly earnings data on Wednesday, July, 16th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.06. The company earned $649.61 million during the quarter, compared to analyst estimates of $644.68 million. Swedish Orphan Biovitrum had a net margin of 16.05% and a trailing twelve-month return on equity of 11.67%.

Shares of BIOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/16/2025
Today
8/24/2025
Next Earnings (Estimated)
10/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOVF
CIK
N/A
Fax
N/A
Employees
1,937
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
$1.19
Trailing P/E Ratio
25.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$367.52 million
Net Margins
16.05%
Pretax Margin
18.72%
Return on Equity
11.67%
Return on Assets
6.34%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
1.00
Quick Ratio
0.66

Sales & Book Value

Annual Sales
$2.46 billion
Price / Sales
4.45
Cash Flow
$2.05 per share
Price / Cash Flow
14.99
Book Value
$11.36 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
356,000,000
Free Float
N/A
Market Cap
$10.95 billion
Optionable
Not Optionable
Beta
0.46

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:BIOVF) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners